by Market Overview:
An Automated Patch Clamp System is a robotic instrument that automates the entire patch clamping workflow in order to study ion channels and receptors. Patch clamp technique is extensively used in the screening of target molecules during the drug discovery process. The automated systems screen thousands of cells or compounds much faster than the manual patch clamp. Major players in the market are focusing on developing high throughput systems for large scale screening during early drug discovery.
Market Dynamics:
Rising prevalence of diseases like cancer, neurological disorders, and cardiac diseases is propelling pharmaceutical and biotech companies to focus on drug discovery through ion channel screening, which is driving the demand for automated patch clamp systems. Additionally, extensive R&D activities in the field of pharmacology and electrophysiology across academic and research institutes is also positively impacting the market growth. Furthermore, development of advanced systems with expanded capabilities is further fuelling the adoption. However, high costs of these systems and frequent upgrades may hinder the market growth over the forecast period.
Segment Analysis
The global automated patch clamp system market is segmented into chip-based systems and parallel patch clamp systems. The chip-based systems segment dominated the market in 2023 due to increasing demand for higher throughput screening. Chip-based systems facilitate the screening of a large number of compounds simultaneously on miniaturized ion channel chips, thereby enabling high-throughput screening and reducing reagent costs significantly.
The global Automated Patch Clamp System Market Size is estimated to be valued at US$ 412.01 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
PEST Analysis
Political: Governments across countries are supporting life science research through funding. For instance, the U.S. government funds the National Institutes of Health (NIH) to support medical research.
Economic: The rising incidence of target diseases such as cancer, cardiac diseases, and neurological disorders is expected to fuel demand for novel drugs, boosting market growth.
Social: Increasing public-private partnerships for drug discovery and rising healthcare expenditure are expected to support the adoption of automated patch clamp systems.
Technological: Advancements in microfluidics and robotics technology have enabled the development of next-generation high-throughput systems with improved functionality. Miniaturization of assays has also enhanced screening capacity.
Key Takeaways
The global automated patch clamp system market is expected to witness high growth, exhibiting a CAGR of 6.9% over the forecast period, due to increasing funding for life science research globally. The U.S. dominated the North America region in 2023 led by availability of research funding and presence of major players. With increasing R&D investments by pharmaceutical companies and growing biotechnology industry, Asia Pacific region is anticipated to be the fastest-growing regional market during the analysis period. Key players operating in the automated patch clamp market are Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH among others. Advancements in system features by these players will further drive market growth and adoption.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
